Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Rankning i aktier #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Aktiekurs
$2.10
Senast synkroniserad: 2026-08-21
Marknadsvärde
$104.43M
Förändring (1 dag)
-2.10%
Förändring (1 år)
-
Land
US
Handel Polaryx Therapeutics, Inc. Common Stock (PLYX)

Kategori

Aktiekurshistorik för Polaryx Therapeutics, Inc. Common Stock (PLYX)
Högsta slutkurs: $2.23 den 2026-08-01

Lägsta slutkurs: $7.90 den 2026-02-01
Aktiekurshistorik för Polaryx Therapeutics, Inc. Common Stock från 2026 till 2026
Årlig aktiekursutveckling
År Prestanda
Inte tillräckligt med data för de angivna datumen.
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH